sal next-generation sequencing (NGS)-based oncology test system. In September 2014, Sanofi and MyoKardia, Inc. announced a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most common forms of heart muscle disease. History The company was founded in 1970. It was formerly known as Sanofi-Aventis and changed its name to Sanofi in 2011.
54, Rue La Boétie
Phone: 33 1 53 77 40 00
|Amgen Inc||$141.63 USD||+0.92|
|Bayer AG||€112.10 EUR||+5.78|
|Gilead Sciences Inc||$105.32 USD||+1.48|
|GlaxoSmithKline PLC||1,437 GBp||+2.50|
|Merck & Co Inc||$60.11 USD||+0.2328|
|View Industry Companies|
Sponsored Financial Commentaries
To contact SANOFI-TITR PART10%87, please visit www.sanofi-aventis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.